U24HL163114
Cooperative Agreement
Overview
Grant Description
Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Resource and Coordinating Center - Poor cardiovascular health (CVH) contributes to high levels of morbidity and mortality in the United States, with profound health disparities by race/ethnicity, socioeconomic status, and geography.
Sustained improvement in CVH requires 2-generation strategies in settings where those at elevated risk for poor CVH already receive care. Evidence-based home visiting (HV) provides an ideal setting to reduce health disparities, reduce maternal morbidity, and promote CVH in infants and children in ways that can be continued across the life course.
Prior studies of CVH intervention effectiveness have not tested interventions across HV models, incorporated emerging technologies such as mHealth and telehealth, combined HV with services in other settings where mothers and children receive care, acknowledged mediators and moderators of effectiveness, nor used individual and composite maternal and child CVH metrics to assess outcomes.
The Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) program aims to address these limitations. It will test a common implementation-ready intervention to promote maternal and child CVH and reduce CVH disparities in the context of multiple evidence-based HV models.
The success of ENRICH requires a Resource and Coordinating Center (RCC) with sophisticated content and methods expertise and resources to support study design and implementation of a common intervention and research protocol attuned to heterogeneity in individual, family, and community context.
The Johns Hopkins RCC multidisciplinary team combines the expertise of the Home Visiting Applied Research Collaborative (HARC), the Johns Hopkins Center for Clinical Trials and Evidence Synthesis (CCTES), and the Johns Hopkins Center for Health Equity. This RCC team offers an unparalleled combination of a national HV platform, expertise in health equity, and clinical trials infrastructure to create new management strategies, organization concepts, and impactful analyses to assure that ENRICH achieves its potential.
Our RCC includes:
(1) Stakeholder-built HV precision paradigm;
(2) Content expertise and leadership in HV and CVH;
(3) State-of-the-art methods to design and implement a common protocol, analyze data, disseminate results, and translate for policy and practice;
(4) Advanced methods to assess "what works best, for whom, in which contexts, why and how?" and assess ideal CVH metrics for both mothers and children;
(5) Tight linkage with HV and CVH stakeholders; and
(6) Expertise in engaging and training early-stage investigators and HV staff professionals.
The RCC will apply the strengths of three JHU divisions (Public Health, Medicine, and Nursing) to ENRICH to generate impactful evidence on effectiveness of the ENRICH intervention and powerful data on generalizability to enhance translation.
The RCC will assure that ENRICH achieves its full potential and generates rigorous, innovative, timely, and actionable new knowledge to reduce maternal morbidity, promote CVH, and reduce CVH disparities in mothers and young children.
Sustained improvement in CVH requires 2-generation strategies in settings where those at elevated risk for poor CVH already receive care. Evidence-based home visiting (HV) provides an ideal setting to reduce health disparities, reduce maternal morbidity, and promote CVH in infants and children in ways that can be continued across the life course.
Prior studies of CVH intervention effectiveness have not tested interventions across HV models, incorporated emerging technologies such as mHealth and telehealth, combined HV with services in other settings where mothers and children receive care, acknowledged mediators and moderators of effectiveness, nor used individual and composite maternal and child CVH metrics to assess outcomes.
The Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) program aims to address these limitations. It will test a common implementation-ready intervention to promote maternal and child CVH and reduce CVH disparities in the context of multiple evidence-based HV models.
The success of ENRICH requires a Resource and Coordinating Center (RCC) with sophisticated content and methods expertise and resources to support study design and implementation of a common intervention and research protocol attuned to heterogeneity in individual, family, and community context.
The Johns Hopkins RCC multidisciplinary team combines the expertise of the Home Visiting Applied Research Collaborative (HARC), the Johns Hopkins Center for Clinical Trials and Evidence Synthesis (CCTES), and the Johns Hopkins Center for Health Equity. This RCC team offers an unparalleled combination of a national HV platform, expertise in health equity, and clinical trials infrastructure to create new management strategies, organization concepts, and impactful analyses to assure that ENRICH achieves its potential.
Our RCC includes:
(1) Stakeholder-built HV precision paradigm;
(2) Content expertise and leadership in HV and CVH;
(3) State-of-the-art methods to design and implement a common protocol, analyze data, disseminate results, and translate for policy and practice;
(4) Advanced methods to assess "what works best, for whom, in which contexts, why and how?" and assess ideal CVH metrics for both mothers and children;
(5) Tight linkage with HV and CVH stakeholders; and
(6) Expertise in engaging and training early-stage investigators and HV staff professionals.
The RCC will apply the strengths of three JHU divisions (Public Health, Medicine, and Nursing) to ENRICH to generate impactful evidence on effectiveness of the ENRICH intervention and powerful data on generalizability to enhance translation.
The RCC will assure that ENRICH achieves its full potential and generates rigorous, innovative, timely, and actionable new knowledge to reduce maternal morbidity, promote CVH, and reduce CVH disparities in mothers and young children.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Baltimore,
Maryland
212182608
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 04/30/29 to 06/30/29 and the total obligations have increased 11131% from $62,500 to $7,019,236.
The Johns Hopkins University was awarded
ENRICH Multisite Resource and Coordinating Center
Cooperative Agreement U24HL163114
worth $7,019,236
from National Heart Lung and Blood Institute in May 2022 with work to be completed primarily in Baltimore Maryland United States.
The grant
has a duration of 7 years 1 months and
was awarded through assistance program 93.837 Cardiovascular Diseases Research.
The Cooperative Agreement was awarded through grant opportunity Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Resource and Coordinating Center (U24 Clinical Trial Required).
Status
(Ongoing)
Last Modified 8/5/26
Period of Performance
5/5/22
Start Date
6/30/29
End Date
Funding Split
$7.0M
Federal Obligation
$0.0
Non-Federal Obligation
$7.0M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U24HL163114
Transaction History
Modifications to U24HL163114
Additional Detail
Award ID FAIN
U24HL163114
SAI Number
U24HL163114-3428442079
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NH00 NIH National Heart, Lung, and Blood Institute
Funding Office
75NH00 NIH National Heart, Lung, and Blood Institute
Awardee UEI
FTMTDMBR29C7
Awardee CAGE
5L406
Performance District
MD-07
Senators
Benjamin Cardin
Chris Van Hollen
Chris Van Hollen
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Heart, Lung, and Blood Institute, National Institutes of Health, Health and Human Services (075-0872) | Health research and training | Grants, subsidies, and contributions (41.0) | $2,228,419 | 71% |
| Office of the Director, National Institutes of Health, Health and Human Services (075-0846) | Health research and training | Grants, subsidies, and contributions (41.0) | $705,028 | 23% |
| National Institute on Minority Health and Health Disparities, National Institutes of Health, Health and Human Services (075-0897) | Health research and training | Grants, subsidies, and contributions (41.0) | $125,000 | 4% |
Modified: 8/5/26